Electrical nano-membrane pulses hormone drugs

Portability makes electrical stimulation the control method of choice for pulsatile drug delivery, say South Korean researchers. They've been working on just such a delivery mechanism, which holds promise for use in new therapeutic methods being devised for hormone-related conditions, including infertility, dwarfism and diabetes.

A device built by Jin Kon Kim and his team at Pohang University of Science Technology uses a nanoporous membrane made of electrically responsive polymers to provide both pulsed and on-demand drug release, reports Nanowerks.

Electrochemical state changes control the nanopore openings. At the reduction state, pores close due to expansion of the polymer, trapping the drug inside. The pores open during the oxidation state, releasing the drug. Each state is reversible more than 1000 times. Switching time is less than 10 seconds.

The implantable unit improves over previous electrical pulsation delivery devices, according to Kim. Earlier devices had drug-reservoir and switch limitations as well as quantity-release control problems. And the new device requires a driving potential of just 1.1 volts, practically one-third of that used to run an artificial heart.

-here's the article

Suggested Articles

J&J figures its partner Genmab owes a share of Darzalex Faspro royalties to Halozyme for its subcutaneous delivery tech. Genmab doesn't agree.

Bexson Biomedical and Stevanato Group teamed up to develop a ketamine pump that may help patients better manage pain at home.

Australia's University of New South Wales and Uka Tarsadia University in India will join forces to explore contact lenses for ocular drug delivery.